Lantheus Holdings, Inc. Cost of Goods Sold (Deprecated 2018-01-31)
Lantheus Holdings, Inc. (LNTH) reported Cost of Goods Sold (Deprecated 2018-01-31) of $40.32 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-02.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-05-02
- Lantheus Holdings, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $40.32M, a 3.07% decline year-over-year.
- Lantheus Holdings, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $43.34M, a 9.17% increase year-over-year.
- Lantheus Holdings, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $41.41M, a 5.16% increase year-over-year.
- Lantheus Holdings, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $42.89M, a 1.60% increase year-over-year.
- Lantheus Holdings, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $169.24M, a 3.15% increase from fiscal 2016.
- Lantheus Holdings, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $164.07M, a 3.88% increase from fiscal 2015.
- Lantheus Holdings, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $157.94M, a 10.30% decline from fiscal 2014.
- Lantheus Holdings, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $176.08M, a 14.65% decline from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $40.32M 10-Q · filed 2018-05-02 | $83.66M derived: sum of 2 quarters · filed 2018-05-02 | $125.08M derived: sum of 3 quarters · filed 2018-05-02 | $167.97M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-12-31 | $43.34M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $84.76M derived: sum of 2 quarters · filed 2018-02-26 | $127.65M derived: sum of 3 quarters · filed 2018-02-26 | $169.24M 10-K · filed 2018-02-26 |
| 2017-09-30 | $41.41M 10-Q · filed 2017-11-02 | $84.30M derived: sum of 2 quarters · filed 2017-11-02 | $125.90M 10-Q · filed 2017-11-02 | $165.60M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-06-30 | $42.89M 10-Q · filed 2017-08-01 | $84.49M 10-Q · filed 2017-08-01 | $124.19M derived: sum of 3 quarters · filed 2018-05-02 | $163.57M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-03-31 | $41.60M 10-Q · filed 2018-05-02 | $81.30M derived: sum of 2 quarters · filed 2018-05-02 | $120.68M derived: sum of 3 quarters · filed 2018-05-02 | $162.90M derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | $39.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $79.08M derived: sum of 2 quarters · filed 2018-02-26 | $121.30M derived: sum of 3 quarters · filed 2018-02-26 | $164.07M 10-K · filed 2018-02-26 |
| 2016-09-30 | $39.38M 10-Q · filed 2017-11-02 | $81.60M derived: sum of 2 quarters · filed 2017-08-01 | $124.37M 10-Q · filed 2017-11-02 | $162.19M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $42.22M 10-Q · filed 2017-08-01 | $84.99M 10-Q · filed 2017-08-01 | $122.81M derived: sum of 3 quarters · filed 2018-02-26 | $163.23M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $42.77M 10-Q · filed 2017-05-02 | $80.59M derived: sum of 2 quarters · filed 2018-02-26 | $121.01M derived: sum of 3 quarters · filed 2018-02-26 | $161.66M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $37.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $78.24M derived: sum of 2 quarters · filed 2018-02-26 | $118.89M derived: sum of 3 quarters · filed 2018-02-26 | $157.94M 10-K · filed 2018-02-26 |
| 2015-09-30 | $40.42M 10-Q · filed 2016-11-01 | $81.06M derived: sum of 2 quarters · filed 2016-11-01 | $120.12M 10-Q · filed 2016-11-01 | $164.33M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $40.65M 10-Q · filed 2016-08-04 | $79.70M 10-Q · filed 2016-08-04 | $123.91M derived: sum of 3 quarters · filed 2017-02-23 | $167.95M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $39.05M 10-Q · filed 2016-05-03 | $83.26M derived: sum of 2 quarters · filed 2017-02-23 | $127.31M derived: sum of 3 quarters · filed 2017-02-23 | $171.86M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $44.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $88.25M derived: sum of 2 quarters · filed 2017-02-23 | $132.81M derived: sum of 3 quarters · filed 2017-02-23 | $176.08M 10-K · filed 2017-02-23 |
| 2014-09-30 | $44.04M 10-Q · filed 2015-11-04 | $88.60M derived: sum of 2 quarters · filed 2015-11-04 | $131.87M 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $44.55M 10-Q · filed 2015-08-05 | $87.83M 10-Q · filed 2015-08-05 | ||
| 2013-12-31 | $206.31M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |